Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

No unexpected CRISPR-Cas9 off-target activity revealed by trio sequencing of gene-edited mice.

Iyer V, Boroviak K, Thomas M, Doe B, Riva L, Ryder E, Adams DJ.

PLoS Genet. 2018 Jul 9;14(7):e1007503. doi: 10.1371/journal.pgen.1007503. eCollection 2018 Jul.

2.

Author Correction: Revealing hidden complexities of genomic rearrangements generated with Cas9.

Boroviak K, Fu B, Yang F, Doe B, Bradley A.

Sci Rep. 2018 Apr 5;8(1):5765. doi: 10.1038/s41598-018-23232-6.

3.

Revealing hidden complexities of genomic rearrangements generated with Cas9.

Boroviak K, Fu B, Yang F, Doe B, Bradley A.

Sci Rep. 2017 Oct 9;7(1):12867. doi: 10.1038/s41598-017-12740-6. Erratum in: Sci Rep. 2018 Apr 5;8(1):5765.

4.

Synthetic lethality between PAXX and XLF in mammalian development.

Balmus G, Barros AC, Wijnhoven PW, Lescale C, Hasse HL, Boroviak K, le Sage C, Doe B, Speak AO, Galli A, Jacobsen M, Deriano L, Adams DJ, Blackford AN, Jackson SP.

Genes Dev. 2016 Oct 1;30(19):2152-2157.

5.

C13orf31 (FAMIN) is a central regulator of immunometabolic function.

Cader MZ, Boroviak K, Zhang Q, Assadi G, Kempster SL, Sewell GW, Saveljeva S, Ashcroft JW, Clare S, Mukhopadhyay S, Brown KP, Tschurtschenthaler M, Raine T, Doe B, Chilvers ER, Griffin JL, Kaneider NC, Floto RA, D'Amato M, Bradley A, Wakelam MJ, Dougan G, Kaser A.

Nat Immunol. 2016 Sep;17(9):1046-56. doi: 10.1038/ni.3532. Epub 2016 Aug 1.

PMID:
27478939
6.

Chromosome engineering in zygotes with CRISPR/Cas9.

Boroviak K, Doe B, Banerjee R, Yang F, Bradley A.

Genesis. 2016 Feb;54(2):78-85. doi: 10.1002/dvg.22915. Epub 2016 Jan 25.

Supplemental Content

Loading ...
Support Center